A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy

Neuro-Oncology

Volumn 18, Issue 6, 2016, Pages 849-854

  Lee, Eudocia Q ^a,b   Muzikansky, Alona ^c   Drappatz, Jan ^d   Kesari, Santosh ^e   Wong, Eric T ^b,f   Fadul, Camilo E ^g,h   Reardon, David A ^a,b   Norden, Andrew D ^a,b   Nayak, Lakshmi ^a,b   Rinne, Mikael L ^a,b   Alexander, Brian M ^a,b   Arvold, Nils D ^a,b   Doherty, Lisa ^a   Stefanik, Jennifer ^a   Lafrankie, Debra ^a   Ruland, Sandra F ^a   Pulverenti, Julee ^a   Smith, Katrina H ^a   Gaffey, Sarah C ^a   Hammond, Samantha ^a   Wen, Patrick Y ^a,b   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^h DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

armodafinil; clinical trial; fatigue; glioblastoma; glioma

Indexed keywords

ARMODAFINIL; BEVACIZUMAB; PLACEBO; TEMOZOLOMIDE; BENZHYDRYL DERIVATIVE; WAKEFULNESS PROMOTING AGENT;

ABDOMINAL PAIN; ADULT; AGED; AGITATION; ARTICLE; BRIEF FATIGUE INVENTORY; CANCER FATIGUE SCALE; CANCER RADIOTHERAPY; COLON OBSTRUCTION; CONFUSION; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DRUG EFFECT; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE; GLAUCOMA; GLIOMA; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; ILEUS; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PILOT STUDY; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SPEECH DISORDER; THROMBOCYTOPENIA; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; DOUBLE BLIND PROCEDURE; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RADIOTHERAPY; TREATMENT OUTCOME; WAKEFULNESS-PROMOTING AGENTS;

EID: 84975168285     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/now007     Document Type: Article

References (19)

1. Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro Oncol. 2012;14(Suppl 4):iv65-iv72.
2. Lovely M, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiformae. Oncol Nurs Forum. 1999;26(5):921-925.
3. Schiff D, Lee EQ, Nayak L, Norden AD, Reardon DA,Wen PY. Medical management of brain tumors and the sequelae of treatment. Neuro Oncol. 2015;17(4):488-504.
4. Page BR, Shaw EG, Lu L, et al. Phase II double-blind placebocontrolled randomized study of armodafinil for brain radiationinduced fatigue. Neuro Oncol. 2015;17(10):1393-401.
5. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570-579.
6. Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006;24(13):2073-2078.
7. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94(2):528-538.
8. Okuyama T, Akechi T, Kugaya A, et al. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage. 2000;19(1):5-14.
9. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186-1196.
10. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991; 10(4):585-598.
11. Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996;52(4):1324-1333.
12. Ratitch B, O'Kelly M. Implementation of Pattern-Mixture Models Using Standard SAS/STAT Procedures. Paper presented at: PharmaSUG Annual Conference; 8-11 May 2011; Nashville, TN.
13. National Research Council (US) Panel on Handling Missing Data in Clinical Trials. The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: National Academies Press; 2010. Available from: http://www.ncbi.nlm.nih.gov/books/NBK209904/. doi: 10.17226/12955.
14. Boele FW, Douw L, de Groot M, et al. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro Oncol. 2013;15(10):1420-1428.
15. Butler JM Jr., Case LD, Atkins J, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69(5): 1496-1501.
16. Spathis A, Fife K, Blackhall F, et al. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol. 2014;32(18): 1882-1888.
17. de Raaf PJ, van der Rijt CC. Can you help me feel less exhausted all the time? J Clin Oncol. 2013;31(25):3056-3060.
18. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013;31(25):3076-3082.
19. Alliance for Clinical Trials in Oncology; National Cancer Institute. Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma. 2013-[cited 2015 July 15]. Available from: http://clinicaltrials.gov/show/NCT01781468 NLM Identifier: NCT01781468; https://clinicaltrials.gov/ct2/show/NCT01781468. Accessed July 15, 2015.